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This investigation sought to determine the feasibility of a novel 
mitral ring designed to reshape mitral annulus on beating heart, 
after surgery. The mitral ring is intended to improve mitral 
leaflets coaptation to correct residual and recurrent mitral 
regurgitations. It could also provide progressive correction of 
mitral regurgitation. The device was tested in ex vivo beating 
heart model. The novel mitral ring is selectively deformable in 
P1, P2, and P3 segments using a dedicated angioplasty-type 
balloon. The deformation should increase leaflets coaptation, 
reducing distance between the two leaflets. It was implanted 
using standard surgical techniques. The mock loop is based on 
passive beating heart. Mitral valve (MV) functioning was eval-
uated in terms of leaflets coaptation height at P2 level using 
epicardial echocardiography. The test has been completed on 
eight swine hearts. Ring size was 30 mm. The balloons were 
inserted in the connecting line. Each segment of the posterior 
annulus was independently activated over three progressive 
positions. Balloon inflation pressures were between 15 and 
21 bar. Maximum coaptation height increase was 7 mm. Mean 
pressure gradient across the MV was 1.7 ± 0.3 mm Hg after 
complete activation of the device. The device allowed signifi-
cant increase in coaptation height at P2 level after adjustments 
at P1, P2, and P3. Results were consistent and reproducible. 
This feasibility study demonstrates the possibility to reshape 
the mitral annulus on beating heart to precisely increase MV 
leaflets coaptation height. ASAIO Journal 2017; 63:168–173.
Key Words: mitral valve repair annuloplasty, mitral regurgita-
tion, surgical mitral repair, heart failure, mitral repair ring, 
minimally invasive mitral repair
The surgical repair of mitral regurgitation (MR), in some 
patients, could become a real challenge even for experienced 
cardiac surgeons. In some degenerative MR, the complex 
reconstruction could culminate in residual MR that is typically 
underestimated under general anesthesia. If the residual MR is 
more than moderate, the surgeon tends to replace the valve 
even if the replacement harms left ventricular remodeling and 
has negative impact on long-term survival.1 In case of less than 
moderate residual MR, the surgeon tends to accept the compro-
mise of incomplete repair of the regurgitation. Both solutions 
are frustrating for the surgeon and have negative impact on 
patient’s long-term outcome.1,2 In some functional MRs associ-
ated with poor left ventricular function, the complete correc-
tion of the MR with an undersized ring is historically associated 
with postoperative left heart failure due to the sudden increase 
in the left ventricle afterload.3,4 Therefore, the surgeon has to 
choose between leaving the MR untreated and let the disease 
take its fatal course or being ready to use inotropic and circu-
latory support in the postoperative phase which dramatically 
increases the mortality and morbidity risks.4 Both the surgeon 
and the patient are uncomfortable with these solutions.
Independently from the pathophysiology, regurgitation is 
always a lack of leaflets coaptation. A device able to increase 
the coaptation length of mitral leaflets only in the area where 
residual or recurrent MR is present would definitely improve 
the quality of the surgical repair and probably the clinical 
outcome, potentially reducing the need for mitral valve (MV) 
replacement. Also a device able to progressively increase 
mitral leaflets coaptation would allow the progressive increase 
in the afterload of the left ventricle, possibly reducing postop-
erative complications in patients with poor left ventricle func-
tion.3 A device that could perform both these functions with a 
transcatheter approach would avoid reoperation.
In this article, we present a device for MV annuloplasty con-
ceived for reshaping the mitral annulus after surgical implanta-
tion using transcatheter technique.
The primary end-point of the study is to validate the hypoth-
esis that a novel mitral ring can increase the coaptation height 
of MV leaflets on ex vivo beating heart in a mock circulatory 
loop. Secondary end-points are to assess the technical feasibil-
ity of the procedure and the functional assessment of the MV.
Materials and Methods
Device Description
The MitralMaster (MiMa) (Kephalios SA, Aix-en-Provence, 
France) is an original ring for MV annuloplasty adding to the 
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functional features of the classic Carpentier-edwards mitral 
ring, the possibility of reshaping the mitral annulus any time 
after the surgical implant. The reshaping process could be 
done in several steps and over the time. The device consists 
of rigid ring sutured to the mitral annulus using interrupted 
suture technique and a connecting line that links the ring to 
the subcutaneous tissue where it would be easy to access any 
time after the operation. The connecting line allows a dedicate 
balloon to reach mitral annulus from skin incision using trans-
catheter technique, under echocardiographic or fluoroscopic 
guidance. The balloon is inflated with saline solution, deflated 
after 15 seconds, and then retrieved. The balloon catheter is 
not permanently implanted. Balloon inflation results in per-
manent ring deformation, and the ring itself guarantees the 
durability of the deformation (Figures 1 and 2). It is the ring 
itself that guarantees the durability of the deformation. Defor-
mation segments of the ring correspond to the anatomical 
regions of the posterior mitral annulus P1, P2, and P3. each 
segment can be deformed independently from other segments 
(Figure 3). each segment has a deformation range of 1–5 mm 
(Figure 2). The balloon is retrieved at the end of the procedure. 
The connecting line stays in place. The deformation of the ring 
is intended to increase mitral leaflets coaptation, reducing the 
distance between anterior and posterior leaflets.
Mock Circulatory Loop with Passive Beating Heart
The mock loop was described in detail elsewhere.5,6 It 
consisted of a pulsatile volumetric pump, a hydraulic after-
load mimicking the input impedance of the human systemic 
circulation, and an atrial preload that closed the hydraulic 
loop. The mock loop was instrumented to allow for experi-
mental hydrodynamic investigation on the implanted device 
in simulated rest conditions. Pressures were acquired with 
piezoelectric transducers (140PC series, Honeywell Inc., 
Morristown, nJ) placed in the systemic impedance simula-
tor (Psis, Figure 4), in left atrium and in the ventricle (Patr and 
Pven, respectively). Mitral valve and atrio-ventricular (AV) flow 
rates (Qmv and Qav, respectively) were acquired with time-
transient flow meters equipped with 1" probes (HT110R, 
Transonic Systems Inc., Ithaca, ny). one probe was placed 
upstream from the MV, and the other downstream to the AV. 
Data were sampled at 200 Hz and recorded with an A/D 
board (uSB6210, national Instruments, Austin, TX).
Experimental Procedure and Data Collection
In adult swine’s heart, the MV was exposed through left 
atrium incision. The valve was assessed for integrity, and the 
distance between the trigons was measured to select valves 
having this distance between 30 and 32 mm. The ring (size 
30) was then sutured using interrupted suture technique 
with 2/0 Tycron (Figure 5). Sutures’ needles are inserted into 
dedicated “button holes” on the inner surface of the ring to 
simplify the surgical procedure and avoid accidental damage 
of fragile components of the device. In three samples, mitral 
leaflets received ink spot markers to provide a qualitative 
visual evaluation of coaptation area changes. The connecting 
line exits the left atrium at the level of the left atriotomy. The 
heart was housed into the mock loop as elsewhere detailed, 
and the circulation started simulating physiologic rest condi-
tions (60 bpm of heart rate, 65 ml of stroke volume imposed 
by the pump). Saline solution at 37°C was used as working 
fluid. To assess proper working conditions in the mock loop, 
the following quantities were acquired in all the tested sam-
ples after ring implantation:
	 •	 CO:	cardiac	output	evaluated	from	the	AV	flow	curves	(Qav)
	 •	 Part: mean simulated arterial pressure, evaluated from Psis
Moreover, in three heart samples the following hydrody-
namic quantities were evaluated and compared before and 
after ring activation in P1, P2, and P3:
	 •	 Qmv, sys: mean MV systolic leakage evaluated from the MV 
flow curve Qmv
	 •	 ∆Pmv, dia: mean diastolic pressure drop across the MV 
(mean value of Patr − Pven evaluated over the diastole)
A 5 mm diameter fiberscope (enF-gP, olympus Corp, Tokyo, 
Japan) was then inserted in the left atrium to acquire images of 
the MV and the mitral ring during the simulated cardiac cycle. 
Figure 1. Schematic representation of the MiMa working principle. The balloon is inserted in the connecting line (D) and advanced till the 
P2 segment (A and B). The balloon is then inflated causing permanent deformation of the ring in the P2 area (C). After the procedure, the 
balloon is retrieved.
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A cardiac ultrasound (HDI5000, Philips, eindhoven, The neth-
erlands) was used to acquire images of the MV from epicardium 
(Figure 6). Specifically, the height of the mitral leaflets coapta-
tion (HMC) at P2 level was acquired in baseline conditions. 
Then, the balloon was inflated in P2 position at increasing pres-
sures to achieve small, medium, and large displacement of the 
P2 part of the ring. The procedure was repeated for P1 and P3. 
For each sample, a total of 13 echo measurements were taken. 
The changes in HMC were recorded.
Statistical Analysis
Raw data were analyzed calculating mean and standard 
deviation. Pre- and postactivation hydrodynamic data were 
compared with Mann–whitney test. Pearson’s χ2 test was 
applied to sets of categorical data (HMC) to evaluate how 
likely it is that any observed difference between the sets arose 
by chance. A p < 0.05 was considered significant.
Results
The working conditions imposed by the mock loop did not 
change significantly after device activation (p = 0.112). All hearts 
had normal MV regurgitation (Qmv, sys changed from 0.2 ± 0.2 l/
min preactivation to 0.15 ± 0.1 l/min postactivation of the 
device). Ring size was 30 mm, without significant undersizing. 
The measured cardiac output was 3.0 ± 0.6 l/min, with a mean 
simulated systemic pressure of 86 ± 5.0 mm Hg. The working 
conditions imposed by the mock loop did not change signifi-
cantly after device activation (p = 0.112). Mean pressure gradient 
across the MV (ΔPmv, dia) was 1 ± 1.1 mm Hg preactivation, and 
1.7 ± 0.3 mm Hg after complete device activation (p = 0.453). 
The balloons were inserted without resistance and positioned in 
blind, limit switch mode. each segment of the posterior annulus 
(P1, P2, P3) was independently activated over three progressive 
steps (small, medium, large deformation) without technical fail-
ure. Balloon inflation pressures were between 15 and 21 bar. 
After activation of P2 segment, HMC increase was 3.2 ± 0.1 mm; 
activation of both P2 and P1 leads to 5.5 ± 0.2 mm of increase. The 
maximum HMC increase in P2 was 7.0 mm, and was recorded 
after complete activation of the device at maximum balloon pres-
surization. Figure 7 illustrates detailed results. The on-line movie 
(Supplemental Digital Content 1, http://links.lww.com/ASAIo/
A119) recorded from the left atrium qualitatively shows the effect 
on coaptation of device activation. The χ2 between baseline val-
ues and maximal HMC increase was less than 0.01.
Discussion
The future of MV regurgitation treatment is toward first surgi-
cal correction followed by late, iterative percutaneous adjust-
ments of leaflets coaptation, if needed. Although mitral repair 
Figure 2. Schematic representation of progressive deformation of the ring. The P2 segment is displaced toward the anterior leaflet of 
(A) 2 mm, (B) 3 mm, or (C) 5 mm depending on balloon inflation. Maximum displacement is achieved in one or more steps over time, according 
to patient’s need.
Figure 3. The three anatomical segments of the posterior leaflet 
are displaced independently from each other. Maximum expansion 
of the three segments corresponds to the maximum displacement of 
the posterior leaflet toward the anterior leaflet that MiMa can achieve.
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is still considered the gold standard for the surgical treatment 
of functional and degenerative MR, clinicians started to ques-
tioning the durability of the surgical repair, particularly in 
functional MR.2,3 A recent study analyzed the outcomes of sur-
gical treatment of severe ischemic MR comparing repair versus 
replacement and outlined that the recurrence of MR, which was 
mostly moderate in degree, remained a progressive and excess 
hazard for patients undergoing mitral valve repair. During the 
2 year follow-up period, 58.8% of patients in the repair group 
had moderate or severe regurgitation, as compared with 3.8% 
in the replacement group.7 This deficiency in the durability of 
correction of MR confers a predisposition to heart failure, atrial 
fibrillation, and repeat interventions and hospitalizations.7,8
Improving the durability of a surgical procedure that has been 
established almost 40 years ago and is still wildly accepted is 
a real challenge. Starting from the assumption that “coaptation 
is durability,”2 we focused our efforts to improve the height 
of the mitral leaflets coaptation during the surgical repair or 
whenever needed and without upsetting the standard surgi-
cal technique. The key feature of the device evaluated in this 
study is its capability to improve the coaptation height push-
ing the posterior leaflet toward the anterior, therefore, reducing 
the anteroposterior distance of the native mitral annulus. The 
MiMa should allow to control the amount of posterior leaflet 
displacement (from 1 to 5 mm) as well as to define the area 
of displacement (P1, P2, P3 according to surgical classifica-
tion of posterior leaflet areas) as clearly seen from the camera 
placed in the left atrium. All the adjustments should be feasible 
any time after implant and using transcatheter technique. In 
a clinical setting, the access port will be placed in the right 
subclavian region, under the skin, as a standard pacemaker. 
If a residual or recurrent regurgitation is detected, the guid-
ing catheter is surgically exposed and used to introduce the 
dedicate balloon in the area of the posterior mitral leaflet at the 
regurgitation level. Balloon inflation should then displace the 
given area of the posterior leaflet toward the anterior, clearing 
or reducing the regurgitation. This is the first device offering 
the possibility of precisely adjusting mitral leaflets coaptation 
with transcatheter approach at any time and for several times 
after the implant.
The adequate functioning of the MV requires a beating left 
ventricle; therefore, we have chosen a platform with passive 
beating heart that has already been validated for transcatheter 
MV repair evaluation.5 It combines a reliable simulation of 
physiologic MV leaflets movements with the possibility of 
direct vision of the MV and the mitral ring from the left atrium. 
The possibility to modify the preload and the afterload of the 
left ventricle helped us to recreate almost physiologic condi-
tions for a better evaluation of the device tested.
Balloon inflation was constantly associated with MiMa defor-
mation in the targeted area with high reproducible results. The 
deformation length was clearly correlated to pressure infla-
tion in such a way to establish a pressure/deformation curve 
that is used for the preclinical tests. Basically, we identified 
three degrees of displacement (small, medium, large) for each 
of the three areas in which the posterior leaflet is divided as 
illustrated in Figure 7. This unique feature of the device tested 
makes the control of the coaptation surface much more precise 
than other active annuloplasty devices in terms of parts of the 
posterior leaflet (P1, P3, P3) and degree of coaptation (small, 
medium, large). existing reshaping mitral rings (enCore SQ, 
Micardia Co., Irvine, CA) act to reduce the circumference of 
Figure 4. A photography (right) and a schematic of the pulsatile mock loop (left). LV, left ventricle; PD, pulse duplicator; PR, preload res-
ervoir; Pven, ventricular pressure; Patr, left atrium pressure; Psis, arterial pressure; SIS, systemic impedance simulator; Qmv, mitral valve flow; 
Qao, aortic valve flow.
Figure 5. Integrity of the mitral valve has been assessed. Intertri-
gonal distance is 32 mm. The ring (size 30) is sutured on the mitral 
annulus using interrupted 2/0 Tycron sutures. A: The connecting line 
exits the left atrium at the level of the right end of the atrial incision. 
B: A plastic flange is sutured to the aorta to facilitate the connection 
to the mock circuit. A similar flange is inserted into the left ventricle 
trough the apex to connecting the heart to the mock circuit.
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the mitral annulus, similarly to a sphincter and independently 
from the position of the regurgitation. Their action is, therefore, 
less specific and probably less efficient.
Results showed that the increase in HMC was reproducible 
and progressive (see Video, Supplemental Digital Content 1, 
http://links.lww.com/ASAIo/A119). The coaptation in P1 and 
P3 segments was difficult to measure because of the echocar-
diographic window available from the epicardium. Interest-
ingly, in all hearts, the displacement of P1 and P3 segments 
resulted in increase in HMC at P2 level, endorsing the hypoth-
esis that the entire posterior part of the mitral annulus is dis-
placed toward the anterior. The increase in HMC is achieved 
without shrinking the mitral annulus circumference as it occurs 
when the surgeon downsizes the mitral ring to achieve better 
leaflets coaptation.3 This unique feature of the MiMa explains 
why MV gradients were still in the physiologic range even after 
the complete activation of the device.
A potential detrimental effect of moving the posterior 
annulus toward the anterior could be the displacement of 
the leaflets coaptation plane toward the left ventricle outflow 
tract inducing systolic anterior motion (SAM) effect.9 Any 
of the heart treated showed SAM effect; however, we can-
not exclude that, in patients with small left ventricle cham-
ber, hypertrophy of the interventricular septum, and acute 
mitroaortic junction, SAM could appear after complete acti-
vation of the device.
Figure 6. Echocardiogram with epicardic view of the four cavities. a, height of mitral leaflets coaptation; b, ring at the level of A2. LA, left 
atrium; LV, left ventricle.
Figure 7. Detailed results on average coaptation increase (height of mitral leaflets coaptation) associated with small, medium, and large 
deformation of each P segments. The amount of deformation depends on inflation balloon pressure.
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The possibility of progressively correct the MR without itera-
tive surgical interventions opens new therapeutic opportunity 
for functional MR in patients with low left ventricle ejection 
fraction (lVeF). These patients are at high mortality and mor-
bidity risks when undergo mitral repair or replacement10 mainly 
because of the sudden increase in the left ventricle afterload 
after complete correction of the MR. If the afterload increases 
over weeks or months, the left ventricle should have more time 
to adapt to it and this possibly reduces the risk of heart failure. 
The technique for increasing HMC after the surgical implant of 
the MiMa is transcatheter and the procedure could be repeated 
any time after implant and as many times as necessary till the 
complete activation of the device, making it the ideal tool to 
treat functional MR in patients with poor lVeF.
Moreover, the device addresses recurrent MR due to pro-
gressive left ventricle dilatation possibly associated with HF 
progression. each device’s activation produces an anterior dis-
placement of the corresponding part of the posterior leaflet, 
therefore reducing posterior leaflet excursion. This mechanism 
compensates the relative shortening of the chordae due to left 
ventricle dilatation, avoiding the risks of a second intervention.
Conclusions
There is a clear need for less invasive procedures to treat 
heart diseases in high risk patients. This study showed it is 
possible to increase the height of mitral leaflets coaptation 
on beating heart, with transcatheter approach after implant-
ing an original mitral ring. The procedure was consistent with 
reproducible effects. This device could represent the new 
therapeutic option for the treatment of persistent and recurrent 
MR after surgical repair. It could also allow to surgically treat 
MR in low lVeF patients, possibly reducing the complication 
rate associated with standard repair. only the ongoing clinical 
studies will possibly demonstrate that MiMa improves long-
term results of mitral repair, avoids reoperation and rehospital-
ization due to MR, and allows to treat MR in patients with poor 
ventricular function.
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